🇺🇸 FDA
Patent

US 11820815

Human antibodies to human delta like ligand 4

granted A61KA61K2039/505A61P

Quick answer

US patent 11820815 (Human antibodies to human delta like ligand 4) held by REGENERON PHARMACEUTICALS, INC. expires Mon Nov 16 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
REGENERON PHARMACEUTICALS, INC.
Grant date
Tue Nov 21 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 16 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61K, A61K2039/505, A61P, A61P29/00, A61P35/00